Tonix to present TONMYA phase 3 data at pain congress

October 19, 2026 7:01 AM

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced it will present a poster analysis of phase 3 data on TONMYA® (cyclobenzaprine ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found